Senores Pharmaceuticals Ltd share price logo

Senores Pharmaceuticals Ltd

NSE: SENORES

BSE: 544319

Small Cap

Pharma Sector

₹1133.90

-85.30

(-7.00%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Senores Pharmaceuticals shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-9%

Searches for Senores Pharmaceuticals on INDmoney have decreased by 9% over the last 30 days.

Investment activity on INDmoney

+88.72%

Investment activity in Senores Pharmaceuticals among INDmoney users has increased by 88.72% over the last 30 days.

Among the most traded stocks

106th

Senores Pharmaceuticals was the 106th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

13 days

INDmoney investors hold Senores Pharmaceuticals shares for an average of 13 days.

Senores Pharmaceuticals Stock Performance

as on October 30, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,053.40
    ₹1,228.00
    downward going graph

    7.10%

    Downside

    8.30%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹706.00
    ₹1,599.00
    downward going graph

    37.74%

    Downside

    41.02%

    Upside

    downward going graph

Senores Pharmaceuticals share price movements today

Previous Close
₹1,219.20
Open
₹1,219.20
Volume
23.17L
Upper Circuit
₹1,463.00
Lower Circuit
₹975.40
Day's Low - High
₹1,053.40 - ₹1,228.00
52 Week Low - High
₹706.00 - ₹1,599.00

Senores Pharmaceuticals Historical Returns

1 Month Return
-9.66 %
3 Month Return
-6.62 %
1 Year Return
+ 58.09 %
3 Year Return
+ 118.87 %
5 Year Return
+ 118.87 %

Senores Pharmaceuticals Fundamentals

as on October 30, 2026 at 4:01 pm IST

Market Cap

₹5,222.02 Cr

Return on Equity (ROE)

0.84

PE Ratio (TTM)

39.7

Return on capital employed (ROCE)

2.15

Industry PE ratio

51.65

Beta (LTM)

0.87

P/B Ratio

3.73

Dividend Yield

0

PEG Ratio

3.7

Quarterly Earnings Growth YOY

21.51

EPS (TTM)

12.67

Book Value

170.72

Senores Pharmaceuticals Stock Valuation

as on October 30, 2026 at 4:01 pm IST

Senores Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (21.80x)

January 13, 2025

Today (39.70x)

October 29, 2026

Industry (51.65x)

October 29, 2026

Highest (54.61x)

August 19, 2026

LowHigh

Today’s Price to Earnings Ratio: 39.70x

Senores Pharmaceuticals Technical Analysis

Track how Senores Pharmaceuticals technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish1
Bullish11
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.94
Bullish
CCI (20)
242.69
Bearish
RSI (14)
53.1
Neutral
Momentum (10)
1.2
Bullish
ADI (14)
24.79
Neutral
Ultimate Oscillator (7,14,28)
47.37
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1134.23
Bullish
EMA (20)
1134.29
Bullish
VWMA (20)
1134.68
Bullish
SMA (50)
1132.8
Bullish
EMA (50)
1132.47
Bullish
SMA (200)
1128.61
Bullish
EMA (200)
1131.24
Bullish
KAMA (200)
1129.16
Bullish
DEMA (200)
1121.87
Bullish

Senores Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Senores Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Senores Pharmaceuticals Ltd image
Senores Pharmaceuticals Ltd
BUY5,222.0223.77%0.6558398
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
BUY703.856.04%0.6229235
Coral Laboratories Ltd image
Coral Laboratories Ltd
NA172.918.06%0.001685
Vasundhara Rasayans Ltd image
Vasundhara Rasayans Ltd
NA41.35-0.31%0.00535
Godavari Drugs Ltd image
Godavari Drugs Ltd
NA137.0817.94%0.004105
See all

Market expectation of Senores Pharmaceuticals Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Senores Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Sales
78.7
102.44
79.5
98.26
103.02
114.21
130.3
153.36
170.95
175.19
180.21
192.33
Other Income
0.8
1.96
0.48
1.86
5.16
11.77
3.36
5.41
7.39
17.67
2.81
8.94
Total Income
79.5
104.4
80.87
102.49
108.18
125.98
141.35
167.17
178.34
192.86
183.02
201.27
Expenses
63.55
80.05
59.07
77.36
77.33
94.77
103.83
112.25
120.55
127.7
126.45
134.67
Operating Profit
15.15
22.39
20.43
20.9
25.69
19.44
26.47
41.11
50.4
47.49
53.76
57.66
Operating Profit Margin %
19.25%
21.86%
25.7%
21.27%
24.94%
17.02%
20.31%
26.81%
29.48%
27.11%
29.83%
29.98%
Profit Before Interest, Tax and Depreciation
15.95
24.35
21.8
25.13
30.85
31.21
37.52
54.92
57.79
65.16
56.57
66.6
Interest
2.45
3.03
4.82
5.27
6.16
5.3
5.04
6.19
5.33
8.46
7.17
8.77
Depreciation
3.25
3.71
3.52
3.89
4.2
5.23
5.99
8.09
7.86
9.3
9.94
10.25
Profit Before Tax
10.25
17.61
13.46
15.97
20.49
20.68
26.49
40.64
44.6
47.4
39.46
47.58
Tax Paid
3.14
3.43
2.55
2.9
4.06
2.71
5.31
10.52
11.02
10.73
9.01
10.98
Profit After Tax
7.11
14.18
10.91
13.07
16.43
17.97
21.18
30.12
33.58
36.67
30.45
36.6
Total Net profit including share of profit / Loss from associate company
7.11
14.18
10.91
13.07
16.43
17.97
21.18
30.12
33.58
36.67
30.45
36.6
EPS
4.01
8.03
3.39
3.92
5.04
3.81
4.6
6.54
7.29
7.96
6.61
8.85
Actual EPS
4.01
8.03
3.39
3.92
5.04
3.81
4.6
6.54
7.29
7.96
6.61
8.85
Adjusted EPS
4.01
8.03
3.39
3.92
5.04
3.81
4.6
6.54
7.29
7.96
6.61
8.85
Diluted EPS
3.47
8.03
3.39
3.92
5.04
3.81
4.6
6.54
7.29
7.96
6.6
8.82

Senores Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
14.17
35.34
214.52
398.25
632.63
Other Income
0.46
3.68
2.82
19.26
47.06
Total Income
14.63
39.02
217.34
417.51
679.69
Expenses
12.22
22.67
172.92
308.55
464.31
Operating Profit
1.95
12.67
41.6
89.7
168.32
Operating Profit Margin %
13.76%
35.85%
19.39%
22.52%
26.61%
Profit Before Interest, Tax and Depreciation
2.41
16.35
44.42
108.96
215.38
Interest
0.57
2.14
9.45
21.55
25.03
Depreciation
0.71
1.78
10.02
16.84
31.25
Profit Before Tax
1.13
12.43
24.95
70.57
159.1
Tax Paid
0.15
4.01
-7.76
12.23
37.58
Profit After Tax
0.99
8.43
32.71
58.34
121.52
Total Net profit including share of profit / Loss from associate company
0.99
8.43
32.71
58.34
121.52
EPS
1.2
8.87
13.67
16.12
26.39
Actual EPS
1.2
8.87
13.67
16.12
26.39
Adjusted EPS
1.2
8.87
13.67
16.12
26.39
Diluted EPS
1.2
6.65
12.21
16.12
26.39

Senores Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-10.45
-1.08
-25.7
-45.92
Cash Flow from Investing Activities
-24.44
-48.29
-53.73
-429.48
Cash Flow from Financing Activities
36.46
46.25
86.98
573.13
Net Cash Flow
1.58
-3.12
7.55
97.73

Senores Pharmaceuticals Stock Shareholding Pattern

Numbers in percentages

Jul 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Promoters
66.66%
45.76%
45.76%
45.77%
45.78%
45.8%
45.8%
45.82%
45.82%
45.82%
DII
0%
18.61%
11.78%
9.65%
9.51%
8.61%
9.31%
9.61%
9.77%
10.84%
FII
0%
5.51%
4.25%
4.17%
3.67%
4.28%
3.35%
3.64%
6.62%
6.01%
Public
0%
30.11%
38.2%
40.4%
41.04%
41.31%
41.54%
40.93%
37.79%
37.33%
Total Outstanding Shares
3,32,65,865
4,60,53,588
4,60,53,588
4,60,53,588
4,60,53,588
4,60,53,588
4,60,53,588
4,60,53,588
4,60,53,588
4,60,53,588
Total Shareholders
177
43,707
49,518
37,653
36,389
34,917
34,401
34,126
36,498
42,642

Mutual Funds Buying / Exiting Senores Pharmaceuticals

Holdings as of 15 Oct 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Senores Pharmaceuticals

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Bajaj Flexi Cap Fund Direct Growth

Bajaj Flexi Cap Fund Direct Growth

₹45.76 Cr

₹32.49 Cr (+244.94%)

0.66%

TrustMF Small Cap Fund Direct Growth

TrustMF Small Cap Fund Direct Growth

₹39.31 Cr

₹5.66 Cr (+16.81%)

1.24%

Mutual Funds Exiting Senores Pharmaceuticals

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Senores Pharmaceuticals Corporate Actions

View detailed summary of the earnings and dividend history of Senores Pharmaceuticals.

  • Senores Pharmaceuticals Ltd Earnings Results

    Senores Pharmaceuticals Ltd’s net profit jumped 21.96% since last year same period to ₹39.49Cr in the Q2 2026-2027. On a quarterly growth basis, Senores Pharmaceuticals Ltd has generated 28.55% jump in its net profits since last 3-months.

    Read More

Indices Featuring Senores Pharmaceuticals Stock

Check stock indices that include Senores Pharmaceuticals.

BSE Healthcare

₹50,168.37

+474.08 (▲0.95%)

Insights on Senores Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 6.56% to 7.36% in Sep 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, SENORES stock has moved up by 58.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 45.82% of holdings in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.62% to 6.01% in Sep 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 37.79% to 37.33% in Sep 2026 quarter

About Senores Pharmaceuticals Ltd

Senores Pharmaceuticals Limited was originally incorporated as Senores Pharmaceuticals Private Limited through a Certificate of Incorporation dated December 26 2017 issued by the Registrar of Companies Central Registration Centre. Thereafter the name of the Company was changed to Senores Pharmaceuticals Limited upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4 2023 was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms. The Regulated Markets business is focused on Regulated Markets of US and Canada. The Company has adopted a strategy of identifying developing and commercializing specialty and complex niche products in the midmarket range and received approvals for 19 ANDAs. Further it develop and manufacture pharmaceutical products across various therapeutic areas for Emerging Markets having a presence across 43 countries. The Company operate a Critical Care Injectables Business supplying critical care injectables to hospitals across India through distributors and manufacture APIs for the domestic market and SAARC countries.In 2021 the Company incorporated a wholly owned subsidiary Senores Pharmaceuticals Inc in the US. It then entered the new segment of API by acquiring Ratnagene Lifescience Private Limited. The Company started domestic business with the launch of the Critical Care Injectables Business in 2022.The Company further acquired majority stake in Havix Group Inc. making it a subsidiary of the Company in 2023. It consolidated presence in emerging markets by acquiring shares in Ratnatris Pharmaceuticals Private Limited making it a Subsidiary of the Company in 2023. The Company has launched CMO product in the US with Jubilant Cadista Pharmaceuticals Inc. in 2024. The Company is planning to raise money from public through IPO by issue and allotment of 2700000 Equity Shares through Offer for Sale and Rs 500 Crores equity funds through Fresh Issue..

Revenue: ₹192.33Cr as on September 2026 (Q2 FY27)
Net Profit: ₹36.60Cr as on September 2026 (Q2 FY27)
Listing date: 30 Dec, 2024
Chairperson Name: Sanjay Majmudar
OrganisationSenores Pharmaceuticals Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
CEOSanjay Majmudar
E-voting on sharesClick here to vote

FAQs

What is Senores Pharmaceuticals share price today?

Senores Pharmaceuticals share price today stands at ₹1133.9 as on at the close of the market. Senores Pharmaceuticals share today touched a day high of ₹1228 and a low of ₹1053.4.

What is the 52 week high and 52 week low range for Senores Pharmaceuticals share?

Senores Pharmaceuticals touched a 52 week high of ₹1599 and a 52 week low of ₹706. Senores Pharmaceuticals share price today i.e. is closed at ₹1133.9, which is -29.09% down from its 52 week high and 60.61% up from its 52 week low.

What is Senores Pharmaceuticals's market capitalisation today?

Senores Pharmaceuticals market capitalisation is ₹5,222.02 Cr as on .

How to buy Senores Pharmaceuticals shares?

To buy Senores Pharmaceuticals shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SENORES or Senores Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Senores Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Senores Pharmaceuticals trading volume today?

Senores Pharmaceuticals trading volume is 23.17L as on . This means that 23.17L shares of Senores Pharmaceuticals were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Senores Pharmaceuticals shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest in Senores Pharmaceuticals has decreased while investment activity has increased over the past 30 days, and the average INDmoney investor holds the stock for 13 days. This reflects platform activity only and is not investment advice.